Home » Analyst Articles – US

Zacks Investment Research Downgrades Dorman Products (DORM) to Sell

Zacks Investment Research Downgrades Dorman Products (DORM) to Sell

Dorman Products (NASDAQ:DORM) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. According to Zacks, “Dorman Products, Inc. is... 
Community Healthcare Trust (CHCT) Lowered to Sell at Zacks Investment Research

Community Healthcare Trust (CHCT) Lowered to Sell at Zacks Investment Research

Community Healthcare Trust (NYSE:CHCT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday. According to Zacks, “Community Healthcare Trust... 
Cable One (CABO) Stock Rating Lowered by Zacks Investment Research

Cable One (CABO) Stock Rating Lowered by Zacks Investment Research

Cable One (NYSE:CABO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday. According to Zacks, “Cable One, Inc. is a cable company. The Company... 
Zacks Investment Research Downgrades BankFinancial (BFIN) to Sell

Zacks Investment Research Downgrades BankFinancial (BFIN) to Sell

BankFinancial (NASDAQ:BFIN) was downgraded by Zacks Investment Research from a “buy” rating to a “sell” rating in a research note issued on Tuesday. According to Zacks, “BankFinancial Corporation is the... 
FireEye (FEYE) Earns Neutral Rating from Analysts at Mizuho

FireEye (FEYE) Earns Neutral Rating from Analysts at Mizuho

Analysts at Mizuho started coverage on shares of FireEye (NASDAQ:FEYE) in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage set a “neutral” rating on the information security company’s... 
AMADEUS IT HLDG/ADR (AMADY) Rating Lowered to Sell at Zacks Investment Research

AMADEUS IT HLDG/ADR (AMADY) Rating Lowered to Sell at Zacks Investment Research

AMADEUS IT HLDG/ADR (OTCMKTS:AMADY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday. According to Zacks, “Amadeus IT Holding SA... 
Mediwound (MDWD) Given a $15.00 Price Target by Oppenheimer Analysts

Mediwound (MDWD) Given a $15.00 Price Target by Oppenheimer Analysts

Oppenheimer set a $15.00 price target on Mediwound (NASDAQ:MDWD) in a research report sent to investors on Monday morning. The firm currently has a buy rating on the biopharmaceutical company’s stock. Separately, Zacks Investment... 
Navient (NAVI) Rating Reiterated by Oppenheimer

Navient (NAVI) Rating Reiterated by Oppenheimer

Navient (NASDAQ:NAVI)‘s stock had its “hold” rating reissued by stock analysts at Oppenheimer in a report issued on Monday. Other equities research analysts also recently issued research reports about the company.... 
Allergan (AGN) Given a $165.00 Price Target by Royal Bank of Canada Analysts

Allergan (AGN) Given a $165.00 Price Target by Royal Bank of Canada Analysts

Allergan (NYSE:AGN) received a $165.00 price objective from stock analysts at Royal Bank of Canada in a research note issued on Monday. The firm currently has a “hold” rating on the stock. Royal Bank of Canada’s... 
CytomX Therapeutics (CTMX) Given a $34.00 Price Target by HC Wainwright Analysts

CytomX Therapeutics (CTMX) Given a $34.00 Price Target by HC Wainwright Analysts

CytomX Therapeutics (NASDAQ:CTMX) received a $34.00 target price from HC Wainwright in a note issued to investors on Tuesday. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s... 
Industrial Alliance Securities Upgrades TransAlta (TAC) to Buy

Industrial Alliance Securities Upgrades TransAlta (TAC) to Buy

TransAlta (NYSE:TAC) (TSE:TA) was upgraded by stock analysts at Industrial Alliance Securities to a “buy” rating in a research note issued to investors on Tuesday. A number of other equities research analysts have also... 
Raymond James Reiterates Hold Rating for Apple (AAPL)

Raymond James Reiterates Hold Rating for Apple (AAPL)

Apple (NASDAQ:AAPL)‘s stock had its “hold” rating restated by research analysts at Raymond James in a research report issued on Tuesday. A number of other brokerages have also recently weighed in on AAPL. BTIG Research... 
Payment Data Systems (PYDS) Earns “Buy” Rating from Barrington Research

Payment Data Systems (PYDS) Earns “Buy” Rating from Barrington Research

Payment Data Systems (NASDAQ:PYDS)‘s stock had its “buy” rating restated by stock analysts at Barrington Research in a research note issued on Tuesday. They presently have a $5.00 target price on the business services... 
Yum! Brands (YUM) Raised to Buy at Zacks Investment Research

Yum! Brands (YUM) Raised to Buy at Zacks Investment Research

Yum! Brands (NYSE:YUM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The firm currently has a $111.00 price target on the restaurant... 
Torchlight Energy Resources (TRCH) Lowered to Hold at Zacks Investment Research

Torchlight Energy Resources (TRCH) Lowered to Hold at Zacks Investment Research

Torchlight Energy Resources (NASDAQ:TRCH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday. According to Zacks, “Torchlight... 
ANSYS (ANSS) Upgraded at Zacks Investment Research

ANSYS (ANSS) Upgraded at Zacks Investment Research

ANSYS (NASDAQ:ANSS) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The brokerage presently has a $199.00 price objective on the software... 
Manulife Financial (MFC) Upgraded to Buy by Zacks Investment Research

Manulife Financial (MFC) Upgraded to Buy by Zacks Investment Research

Manulife Financial (NYSE:MFC) (TSE:MFC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The brokerage presently has a $19.00 price objective... 
Cabot (CBT) Stock Rating Lowered by TheStreet

Cabot (CBT) Stock Rating Lowered by TheStreet

Cabot (NYSE:CBT) was downgraded by stock analysts at TheStreet from a “b-” rating to a “c+” rating in a research report issued to clients and investors on Friday. A number of other brokerages have also recently... 
Caleres (CAL) Downgraded by TheStreet

Caleres (CAL) Downgraded by TheStreet

TheStreet cut shares of Caleres (NYSE:CAL) from a b- rating to a c rating in a research note published on Friday morning. Several other brokerages also recently issued reports on CAL. Zacks Investment Research downgraded Caleres from... 
Craft Brew Alliance (BREW) Lowered to C+ at TheStreet

Craft Brew Alliance (BREW) Lowered to C+ at TheStreet

Craft Brew Alliance (NASDAQ:BREW) was downgraded by investment analysts at TheStreet from a “b-” rating to a “c+” rating in a research note issued on Friday. BREW has been the topic of several other research... 
Oaktree Specialty Lending (OCSL) Downgraded to C at TheStreet

Oaktree Specialty Lending (OCSL) Downgraded to C at TheStreet

TheStreet downgraded shares of Oaktree Specialty Lending (NASDAQ:OCSL) from a b rating to a c rating in a research report sent to investors on Friday morning. A number of other research firms have also weighed in on OCSL. Zacks Investment... 
Deutsche Bank Downgrades BB&T (BBT) to Hold

Deutsche Bank Downgrades BB&T (BBT) to Hold

BB&T (NYSE:BBT) was downgraded by equities research analysts at Deutsche Bank from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. They presently have... 
Bed Bath & Beyond (BBBY) Upgraded by Loop Capital to “Hold”

Bed Bath & Beyond (BBBY) Upgraded by Loop Capital to “Hold”

Bed Bath & Beyond (NASDAQ:BBBY) was upgraded by Loop Capital from a “sell” rating to a “hold” rating in a research report issued on Tuesday. The brokerage currently has a $14.00 price objective on the retailer’s... 
TD Ameritrade (AMTD) Downgraded by Zacks Investment Research to “Hold”

TD Ameritrade (AMTD) Downgraded by Zacks Investment Research to “Hold”

TD Ameritrade (NASDAQ:AMTD) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday. According to Zacks, “Shares of TD Ameritrade have... 
Stora Enso Oyj (SEOAY) Downgraded by Zacks Investment Research

Stora Enso Oyj (SEOAY) Downgraded by Zacks Investment Research

Stora Enso Oyj (OTCMKTS:SEOAY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday. According to Zacks, “Stora Enso is an integrated forest... 
UBS Group Raises Apple (AAPL) Price Target to $215.00

UBS Group Raises Apple (AAPL) Price Target to $215.00

Apple (NASDAQ:AAPL) had its target price raised by stock analysts at UBS Group from $185.00 to $215.00 in a research report issued to clients and investors on Tuesday, www.benzinga.com reports. The firm presently has a “buy”... 
Antofagasta (ANFGF) Earns Underweight Rating from Barclays

Antofagasta (ANFGF) Earns Underweight Rating from Barclays

Antofagasta (OTCMKTS:ANFGF)‘s stock had its “underweight” rating reaffirmed by equities research analysts at Barclays in a report issued on Tuesday. They presently have a $7.50 price objective on the stock, down from... 
Medpace (MEDP) Downgraded by TheStreet to “C”

Medpace (MEDP) Downgraded by TheStreet to “C”

TheStreet lowered shares of Medpace (NASDAQ:MEDP) from a b rating to a c rating in a report issued on Friday. Several other research firms also recently weighed in on MEDP. BidaskClub downgraded Medpace from a strong-buy rating to... 
Systemax (SYX) Downgraded by TheStreet to C+

Systemax (SYX) Downgraded by TheStreet to C+

Systemax (NYSE:SYX) was downgraded by TheStreet from a “b-” rating to a “c+” rating in a research note issued to investors on Friday. A number of other analysts also recently commented on the company. Zacks... 
Vertex Pharmaceuticals (VRTX) Raised to “Outperform” at William Blair

Vertex Pharmaceuticals (VRTX) Raised to “Outperform” at William Blair

Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by investment analysts at William Blair from a “market perform” rating to an “outperform” rating in a note issued to investors on Tuesday, The Fly reports. VRTX... 
VIENNA INS GRP/S (VNRFY) Rating Increased to Overweight at JPMorgan Chase & Co.

VIENNA INS GRP/S (VNRFY) Rating Increased to Overweight at JPMorgan Chase & Co.

VIENNA INS GRP/S (OTCMKTS:VNRFY) was upgraded by JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Tuesday, The Fly reports. Shares of VNRFY opened at $4.76... 
CME Group (CME) PT Lowered to $193.00 at Barclays

CME Group (CME) PT Lowered to $193.00 at Barclays

CME Group (NASDAQ:CME) had its price target reduced by research analysts at Barclays from $210.00 to $193.00 in a report issued on Tuesday, The Fly reports. The brokerage presently has an “overweight” rating on the financial... 
New Age Beverages (NBEV) Earns Buy Rating from Analysts at Alliance Global Partners

New Age Beverages (NBEV) Earns Buy Rating from Analysts at Alliance Global Partners

Analysts at Alliance Global Partners assumed coverage on shares of New Age Beverages (NASDAQ:NBEV) in a note issued to investors on Tuesday. The brokerage set a “buy” rating and a $8.00 price target on the stock. Alliance... 
J B Hunt Transport Services (JBHT) Downgraded to Sell at Zacks Investment Research

J B Hunt Transport Services (JBHT) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research downgraded shares of J B Hunt Transport Services (NASDAQ:JBHT) from a hold rating to a sell rating in a report published on Monday morning. According to Zacks, “Shares of J.B. Hunt have declined more... 
Golar LNG (GLNG) Rating Increased to Buy at Zacks Investment Research

Golar LNG (GLNG) Rating Increased to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Golar LNG (NASDAQ:GLNG) from a hold rating to a buy rating in a research report released on Monday morning. Zacks Investment Research currently has $24.00 price objective on the shipping... 
AbbVie (ABBV) Rating Lowered to Hold at Argus

AbbVie (ABBV) Rating Lowered to Hold at Argus

Argus cut shares of AbbVie (NYSE:ABBV) from a buy rating to a hold rating in a research note released on Monday morning, Marketbeat.com reports. A number of other brokerages have also recently issued reports on ABBV. Zacks Investment... 
UDR’s (UDR) Hold Rating Reaffirmed at BMO Capital Markets

UDR’s (UDR) Hold Rating Reaffirmed at BMO Capital Markets

BMO Capital Markets restated their hold rating on shares of UDR (NYSE:UDR) in a research note issued to investors on Monday. They currently have a $49.00 price objective on the real estate investment trust’s stock. Several other... 
Philip Morris International (PM) Price Target Increased to $102.00 by Analysts at Citigroup

Philip Morris International (PM) Price Target Increased to $102.00 by Analysts at Citigroup

Philip Morris International (NYSE:PM) had its target price boosted by Citigroup from $90.00 to $102.00 in a report published on Monday morning, The Fly reports. They currently have a buy rating on the stock. PM has been the subject... 
Lexicon Pharmaceuticals (LXRX) Given New $10.00 Price Target at Stifel Nicolaus

Lexicon Pharmaceuticals (LXRX) Given New $10.00 Price Target at Stifel Nicolaus

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its price objective cut by Stifel Nicolaus from $14.00 to $10.00 in a report released on Monday, The Fly reports. They currently have a buy rating on the biopharmaceutical company’s stock. Other... 
MidSouth Bancorp (MSL) Upgraded to “Buy” by Sandler O’Neill

MidSouth Bancorp (MSL) Upgraded to “Buy” by Sandler O’Neill

Sandler O’Neill upgraded shares of MidSouth Bancorp (NYSE:MSL) from a hold rating to a buy rating in a research report report published on Monday morning, Marketbeat Ratings reports. Several other equities research analysts have... 
Twenty-First Century Fox (FOX) Receives “Sell” Rating from Royal Bank of Canada

Twenty-First Century Fox (FOX) Receives “Sell” Rating from Royal Bank of Canada

Royal Bank of Canada reissued their sell rating on shares of Twenty-First Century Fox (NASDAQ:FOX) in a research report released on Monday, The Fly reports. They currently have a $41.00 price objective on the stock. The analysts noted... 
Vistra Energy (VST) Receives New Coverage from Analysts at Morgan Stanley

Vistra Energy (VST) Receives New Coverage from Analysts at Morgan Stanley

Morgan Stanley began coverage on shares of Vistra Energy (NYSE:VST) in a research report released on Monday morning, MarketBeat Ratings reports. The firm issued an overweight rating and a $35.00 target price on the stock. Several other... 
Nightstar Therapeutics (NITE) Lowered to Equal Weight at Barclays

Nightstar Therapeutics (NITE) Lowered to Equal Weight at Barclays

Barclays downgraded shares of Nightstar Therapeutics (NASDAQ:NITE) from an overweight rating to an equal weight rating in a research note published on Monday morning, Marketbeat.com reports. They currently have $26.00 price objective... 
Eagle Materials (EXP) Now Covered by Analysts at SunTrust Banks

Eagle Materials (EXP) Now Covered by Analysts at SunTrust Banks

SunTrust Banks began coverage on shares of Eagle Materials (NYSE:EXP) in a research report released on Monday, MarketBeat Ratings reports. The firm issued a buy rating on the construction company’s stock. A number of other brokerages... 
AxoGen (AXGN) Rating Increased to Buy at BTIG Research

AxoGen (AXGN) Rating Increased to Buy at BTIG Research

BTIG Research upgraded shares of AxoGen (NASDAQ:AXGN) from a neutral rating to a buy rating in a report released on Monday, MarketBeat.com reports. They currently have $28.00 target price on the medical equipment provider’s stock. AXGN... 
TC Pipelines (TCP) Rating Increased to Hold at ValuEngine

TC Pipelines (TCP) Rating Increased to Hold at ValuEngine

ValuEngine upgraded shares of TC Pipelines (NYSE:TCP) from a sell rating to a hold rating in a report issued on Monday morning. TCP has been the topic of a number of other reports. Wolfe Research lowered shares of TC Pipelines from... 
Collegium Pharmaceutical (COLL) Upgraded to “Buy” by Zacks Investment Research

Collegium Pharmaceutical (COLL) Upgraded to “Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL) from a hold rating to a buy rating in a report released on Monday. The firm currently has $18.00 price objective on the specialty pharmaceutical company’s... 
American Woodmark (AMWD) Rating Increased to Sell at ValuEngine

American Woodmark (AMWD) Rating Increased to Sell at ValuEngine

ValuEngine upgraded shares of American Woodmark (NASDAQ:AMWD) from a strong sell rating to a sell rating in a research report sent to investors on Monday morning. A number of other analysts also recently issued reports on AMWD. Robert... 
EnerSys (ENS) Downgraded to Sell at ValuEngine

EnerSys (ENS) Downgraded to Sell at ValuEngine

ValuEngine lowered shares of EnerSys (NYSE:ENS) from a hold rating to a sell rating in a research note published on Monday morning. Several other research analysts have also issued reports on the stock. Zacks Investment Research lowered... 
ValuEngine Downgrades Hydrogenics (HYGS) to Hold

ValuEngine Downgrades Hydrogenics (HYGS) to Hold

ValuEngine lowered shares of Hydrogenics (NASDAQ:HYGS) (TSE:HYG) from a buy rating to a hold rating in a report issued on Monday morning. Several other equities analysts also recently issued reports on HYGS. Zacks Investment Research...